Other serum biomarkers such as AFP-L3, DCP, interleukin-6, interleukin-10, and squamous cell carcinoma antigen were also investigated, while these serum-based tests lack adequate sensitivity and specificity for effective surveillance [58–60]. This evidence concerns the gene AFP and squamous cell carcinoma.